Abstract
The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure. Rest and exercise hemodynamics were evaluated in the baseline state and after 1 week of oral nicardipine therapy (30 mg 3 times daily). In addition, respiratory gas exchange and arteriovenous oxygen difference were measured to assess changes in oxygen utilization. The responses of the sympathetic nervous system were evaluated by measuring plasma norepinephrine concentrations at rest and during maximal exercise. At rest, nicardipine administration was associated with significant reductions in mean systemic arterial pressure, systemic vascular resistance, pulmonary artery wedge pressure and pulmonary arterial pressure, and significant increases in cardiac index and stroke volume index. These effects were maintained during exercise. In contrast to findings with other calcium channel antagonists, no negative inotropic effect of nicardipine was identified. Nicardipine administration was associated with reduction of arteriovenous oxygen difference. Nicardipine had no effect on plasma norepinephrine concentrations, suggesting absence of reflex sympathetic nervous a...Continue Reading
References
Oct 22, 1979·The American Journal of Cardiology·R S Adelstein, D R Hathaway
May 1, 1977·Progress in Cardiovascular Diseases·D T MasonG Lee
Sep 1, 1977·Life Sciences·J D Peuler, G A Johnson
May 1, 1986·Circulation·W N LeimbachA L Mark
Jan 1, 1986·Hypertension·R J CodyJ H Laragh
Mar 1, 1985·Journal of the American College of Cardiology·M A FiferW H Barry
Apr 1, 1985·Journal of the American College of Cardiology·G S FrancisJ N Cohn
Sep 15, 1985·The American Journal of Cardiology·U ElkayamS Rahimtoola
Sep 1, 1982·Journal of Cardiovascular Pharmacology·F BellocciU Manzoli
Dec 1, 1980·The American Journal of Cardiology·P D Henry
Nov 1, 1984·Circulation·R D MagorienD V Unverferth
Nov 1, 1983·The American Journal of Medicine·X E PridaR J Cody
May 1, 1984·Circulation·P B KurnikP A Ludbrook
May 1, 1984·The American Journal of Cardiology·U ElkayamS H Rahimtoola
May 1, 1983·The American Journal of Cardiology·J R Wilson, N Ferraro
May 1, 1982·The American Journal of Medicine·R J CodyJ H Laragh
Mar 1, 1982·Circulation·P A LudbrookB E Sobel
Apr 1, 1980·British Heart Journal·S KlugmannF Camerini
Citations
Jul 1, 1988·Cardiovascular Drugs and Therapy·L H Opie
Jun 1, 1989·Cardiovascular Drugs and Therapy·W J Remme
Nov 1, 1988·Journal of the American College of Cardiology·M Packer
Nov 1, 1989·Journal of the American College of Cardiology·C N AroneyM A Fifer
Nov 1, 1989·Journal of the American College of Cardiology·M Packer
Mar 15, 1993·Journal of the American College of Cardiology·K M BorowM Murphy
Oct 1, 1994·Journal of Cardiac Failure·S W MabeeR J Cody
Jan 1, 1999·Progress in Cardiovascular Diseases·N Mahon, W J McKenna
Jan 1, 1997·Clinical Therapeutics·P E Pool
Sep 1, 1987·Journal of the American College of Cardiology·R J CodyJ H Laragh
Jul 23, 1998·Clinical and Experimental Pharmacology & Physiology·K NoguchiM Sakanashi
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Isabelle MahéJean-François Bergmann
Feb 1, 1993·Cardiovascular Drugs and Therapy·L Dei CasO Visioli
Oct 4, 2007·Journal of the American Geriatrics Society·Paul A Heidenreich, Gregg C Fonarow
Dec 1, 1996·Journal of Cardiac Failure·M A KonstamJ E Udelson
May 1, 1987·The American Journal of Cardiology·W KiowskiF Burkart
Aug 1, 1989·Clinical Cardiology·O Fukyama
Jan 1, 1988·Annals of the New York Academy of Sciences·S H KuboJ N Cohn
Jul 1, 1993·International Journal of Cardiology·J ParameshwarK M Fox
Aug 1, 1993·Circulation·E M GilbertM R Bristow
Feb 3, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Eleanor C Wicks, Lewis C Davies
Jun 1, 1989·Journal of Clinical Pharmacology·W H Frishman
Mar 1, 1994·Journal of Anesthesia·Satoshi KashimotoTeruo Kumazawa
May 1, 1989·Clinical Cardiology·C Pepine